Literature DB >> 22380486

Activation of NF-κB in placentas of women with preeclampsia.

John E Vaughan1, Scott W Walsh.   

Abstract

OBJECTIVE: Placentas are oxidatively stressed during preeclampsia and produce more tumor necrosis factor α (TNFα) and more thromboxane than normal. Oxidative stress may cause these abnormalities by activating nuclear factor-κB (NF-κB). We measured the levels of activated NF-κB in normal and preeclamptic placentas and determined whether oxidative stress activates NF-κB in a trophoblast-like cell line.
METHODS: We used immunohistochemistry to determine the percentage of the total tissue area that stained for the p65 subunit of NF-κB in placentas obtained from normal and preeclamptic pregnancies. In a second set of experiments, we used a reporter plasmid bearing the NF-κB binding site and transfected it into trophoblast-like cells. The cells were incubated with medium control, linoleic acid (LA), an oxidizing solution (Ox), or Ox enriched with LA (OxLA), TNFα, or OxLA plus TNFα for 20 h. Cell lysates were analyzed using a dual luciferase assay kit.
RESULTS: Placentas obtained from women with preeclampsia showed nearly a 10-fold increase in the extent of area stained for activated NF-κB as compared to normal placentas. In cell culture experiments, Ox and OxLA induced a threefold increase in NF-κB activation as compared to medium control or LA. TNFα induced a threefold increase in NF-κB activation. The combination of TNFα with OxLA caused a 10-fold increase in NF-κB activation.
CONCLUSIONS: Placental NF-κB is activated nearly 10-fold in preeclampsia. Oxidative stress causes NF-κB activation in a trophoblast-like cell line, which is enhanced by TNFα. These data suggest that oxidative stress is likely an important in vivo activator of placental NF-κB in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22380486      PMCID: PMC3542769          DOI: 10.3109/10641955.2011.642436

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  34 in total

1.  Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction?

Authors:  T Clausen; S Djurovic; F R Brosstad; K Berg; T Henriksen
Journal:  Am J Obstet Gynecol       Date:  2000-02       Impact factor: 8.661

2.  Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells.

Authors:  P Takacs; S W Kauma; M M Sholley; S W Walsh; M J Dinsmoor; K Green
Journal:  FASEB J       Date:  2000-12-08       Impact factor: 5.191

3.  Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.

Authors:  S W Walsh
Journal:  Am J Obstet Gynecol       Date:  1985-06-01       Impact factor: 8.661

4.  A comparative study of serum soluble vascular cell adhesion molecule-1 and soluble intercellular adhesion molecule-1 in preeclampsia.

Authors:  I Phocas; D Rizos; J Papoulias; K Xyni; A Sarandakou; E Salamalekis
Journal:  J Perinatol       Date:  2000-03       Impact factor: 2.521

5.  AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase.

Authors:  Ralf Dechend; Christiane Viedt; Dominik N Müller; Bernhard Ugele; Ralf P Brandes; Gerd Wallukat; Joon-Keun Park; Jurgen Janke; Peter Barta; Jurgen Theuer; Anette Fiebeler; Volker Homuth; Rainer Dietz; Hermann Haller; Jörg Kreuzer; Friedrich C Luft
Journal:  Circulation       Date:  2003-02-24       Impact factor: 29.690

6.  ED(27) trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype.

Authors:  D A Kniss; Y Xie; Y Li; S Kumar; E A Linton; P Cohen; P Fan-Havard; C W G Redman; I L Sargent
Journal:  Placenta       Date:  2002-01       Impact factor: 3.481

7.  Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia.

Authors:  Courtney E Leik; Scott W Walsh
Journal:  Hypertension       Date:  2004-05-17       Impact factor: 10.190

8.  Oxidative stress reproduces placental abnormalities of preeclampsia.

Authors:  J E Vaughan; S W Walsh
Journal:  Hypertens Pregnancy       Date:  2002       Impact factor: 2.108

9.  Diet-related toxemia in pregnancy. I. Fat, fatty acids, and cholesterol.

Authors:  R Chung; H Davis; Y Ma; O Naivikul; C Williams; K Wilson
Journal:  Am J Clin Nutr       Date:  1979-09       Impact factor: 7.045

10.  The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia.

Authors:  Christy-Lynn M Cooke; Jeremy C Brockelsby; Philip N Baker; Sandra T Davidge
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

View more
  43 in total

1.  Co-stimulatory CD28 and transcription factor NFKB1 gene variants affect idiopathic recurrent miscarriages.

Authors:  Maneesh Kumar Misra; Bharti Singh; Aditi Mishra; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

2.  Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia.

Authors:  Heather D Major; Robert A Campbell; Robert M Silver; D Ware Branch; Andrew S Weyrich
Journal:  Am J Obstet Gynecol       Date:  2014-01-17       Impact factor: 8.661

3.  Trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine induces lipid peroxidation-associated apoptosis via the intrinsic and extrinsic apoptosis pathways in a first-trimester placental cell line.

Authors:  Elana R Elkin; Sean M Harris; Rita Loch-Caruso
Journal:  Toxicol Appl Pharmacol       Date:  2017-11-10       Impact factor: 4.219

4.  Early adversity and the regulation of gene expression: Implications for prenatal health.

Authors:  Shannon L Gillespie; Steve W Cole; Lisa M Christian
Journal:  Curr Opin Behav Sci       Date:  2019-03-29

5.  Gene expression and DNA methylation changes in BeWo cells dependent on tumor necrosis factor-α and insulin-like growth factor-I.

Authors:  Kei Tanaka; Kazuhiko Nakabayashi; Tomoko Kawai; Shinji Tanigaki; Kenji Matsumoto; Kenichiro Hata; Yoichi Kobayashi
Journal:  Hum Cell       Date:  2019-11-13       Impact factor: 4.174

6.  Increased O-Linked N-Acetylglucosamine Modification of NF-ΚB and Augmented Cytokine Production in the Placentas from Hyperglycemic Rats.

Authors:  Vanessa Dela Justina; Jéssica S Gonçalves; Raiany Alves de Freitas; Adriany Dias Fonseca; Gustavo T Volpato; Rita C Tostes; Fernando S Carneiro; Victor Vitorino Lima; Fernanda R Giachini
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

7.  NF-κB-responsive miRNA-31-5p elicits endothelial dysfunction associated with preeclampsia via down-regulation of endothelial nitric-oxide synthase.

Authors:  Suji Kim; Kyu-Sun Lee; Seunghwan Choi; Joohwan Kim; Dong-Keon Lee; Minsik Park; Wonjin Park; Tae-Hoon Kim; Jong Yun Hwang; Moo-Ho Won; Hansoo Lee; Sungwoo Ryoo; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  J Biol Chem       Date:  2018-10-02       Impact factor: 5.157

8.  Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia.

Authors:  Adrian C Eddy; John Aaron Howell; Heather Chapman; Erin Taylor; Fakhri Mahdi; Eric M George; Gene L Bidwell
Journal:  Hypertension       Date:  2019-12-02       Impact factor: 10.190

9.  Evidence of sexual dimorphism in the placental function with severe preeclampsia.

Authors:  S Muralimanoharan; A Maloyan; L Myatt
Journal:  Placenta       Date:  2013-09-29       Impact factor: 3.481

10.  MicroRNA-138 improves LPS-induced trophoblast dysfunction through targeting RELA and NF-κB signaling.

Authors:  Ailan Yin; Qian Chen; Mei Zhong; Bei Jia
Journal:  Cell Cycle       Date:  2021-02-08       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.